Daraxonrasib offers ‘transformational’ benefit in metastatic pancreatic cancer

pharmaceutical-technology.com·Jun 1, 2026 · 3 mesi fa

ASCO26: RevMed’s daraxonrasib presents a turning point for pancreatic cancer - Pharmaceutical Technology

eu.usatoday.com·Jun 1, 2026 · 3 mesi fa

Pancreatic cancer 'miracle' drug daraxonrasib doubles survival rate in new trial

pbs.org·May 30, 2026 · 3 mesi fa

Pancreatic cancer is deadly and difficult to treat. A new pill could change that

independent.co.uk·May 31, 2026 · 3 mesi fa

Daily pill almost doubles survival time for pancreatic cancer patients in new trial

cbsnews.com·May 31, 2026 · 3 mesi fa

New drug nearly doubles survival rates in some pancreatic cancer patients, study says

newsbytesapp.com·Jun 1, 2026 · 3 mesi fa

This drug can double survival time for pancreatic cancer patients

medpagetoday.com·May 31, 2026 · 3 mesi fa

'Grand Slam' in Pancreatic Cancer: Novel Pill Doubles Survival

newscientist.com·Jun 1, 2026 · 3 mesi fa

'Transformative' pancreatic cancer drug doubles survival time

nbcnews.com·May 31, 2026 · 3 mesi fa

After new drug’s ‘unprecedented’ results for pancreatic cancer, doctors look at other uses

biopharmadive.com·May 31, 2026 · 3 mesi fa

‘Unprecedented’ Revolution data point to paradigm shift in pancreatic cancer